InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.00
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
69,157.56
(
-0.22%
)
Post# of 253511
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Superfly15

Send PM Follow Ignore
Followers 36
Posts 2600
Boards Moderated 0
Alias Born 03/23/2010

Superfly15

Re: biomaven0 post# 139358

Wednesday, 03/28/2012 11:39:08 AM

Wednesday, March 28, 2012 11:39:08 AM

Post# of 253511

I've never seen a biotech disclose ahead of an FDA decision that they expect a CRL even when a CRL was inevitable, which I certainly don't believe was the case here.



Transcept did last year.

Transcept Pharmaceuticals Expects Complete Response Letter on Intermezzo® New Drug Application Based on Teleconference with FDA

POINT RICHMOND, Calif., July 12, 2011

ir.transcept.com/releasedetail.cfm?ReleaseID=590916
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up